External reference pricing: the drug pricing reform America needs?

The Commonwealth Fund

27 May 2021 - External reference pricing, sometimes known as international reference pricing, refers to the practice of informing price negotiations in a given country by calculating a benchmark, or reference, price based on publicly available pricing data from one or more other countries.

The rationale for external reference pricing is straightforward — to ensure that the maximum price paid for a drug is not excessive relative to its price in countries that are comparable in terms of economic indicators, structure of the health system, and other factors.

Read The Commonwealth Fund Issues Brief

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing , Comparison